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Available online 10 November 2009The conclusion of this systematic review is that there is
a paucity of high quality studies to assess the extent to which
patients with peripheral arterial occlusive disease (PAOD)
receive secondary preventive therapy. Few of the studies
were prospective, most were cross-sectional and/or retro-
spective and none were randomized. Nevertheless, this
review demonstrated what many of us have already sus-
pected; patients with PAOD rarely receive appropriate
medications and/or life-style guidance according to profes-
sional guidelines.1,2
We still do not know why this should be the case and we
remain at a loss to know what further measures should be
taken in order to meet the challenge of ensuring that each
PAOD patient receives appropriate guidance that will reduce
their risk of secondary cardiovascular events.We can propose
that there might be a lack of knowledge amongst vascular
surgeons. Perhaps surgeons who are comfortable at per-
forming complex procedures feel somewhat out of place in
dealing with the treatment of multiple co-morbidities
(hypertension, hyperlipidaemia etc). Some may be reluctant
to offer patients advice about diet, smoking cessation and
exercise. Perhaps surgeons are resistant to starting four or
five new medications in a patient who has walked into their
consulting room having taken none beforehand. Perhaps
there is not enough time in a busy outpatient clinic for the
surgeon to devote enough attention to secondary preventiveDOI of original article: 10.1016/j.ejvs.2009.09.027.
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doi:10.1016/j.ejvs.2009.10.010measures and, perhaps, patients do not follow advice that
has been given in a hasty or superior manner.
So howmight we, as a profession, increase the proportion
of patients receiving secondary preventive therapy in routine
clinical practice? From previous research, it is evident that
strong leadership is required by the Departmental Head,3
supplemented by easily accessible knowledge sources and
reinforcement of the importance of secondary prevention at
educational meetings.4 It is also likely that continuously
auditing how successful the secondary prevention pro-
gramme is, together with feedback to the responsible
surgeon, will increase the success rate.5 It may also be
necessary to think completely differently. Maybe other
Healthcare professionals could take this burden off the
surgeon? For example, a Nurse led secondary prevention
clinic, supervised by a surgeon/physician, has already been
successfully established in Copenhagen.6 Alternatively,
maybe this might be an ideal role for an Angiologist? Clinics
that provide time to educate and guide patients so that they
can make the right lifestyle choices in an effective way
should be encouraged, in order that patients are then able to
develop an understanding of the nature of their vascular
disease and then take personal responsibility for their care.
Unfortunately, we still do not know which strategy will
best increase the rate of implementation of secondary
prevention guidelines and further studies in this field would
be very helpful. If nothing else, this systematic review has
shown that the current situation cannot be allowed tod by Elsevier Ltd. All rights reserved.
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their practice.
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